• Saturday, Nov 27, 2021
  • Last Update : 11:14 pm

Oxford researchers say they developed blood test predictor of Covid vaccine efficacy

  • Published at 11:13 am June 25th, 2021
Britain coronavirus vaccine Covid-19 AstraZeneca
Brian Pinker, 82, receives the Oxford University/AstraZeneca Covid-19 vaccine from nurse Sam Foster at the Churchill Hospital in Oxford, Britain January 4, 2021 Reuters

More work needed to validate the model for many of the highly contagious new virus variants of concern, researchers caution

Researchers at Oxford University said on Thursday they have developed a method to predict the efficacy of new Covid-19 vaccines based on a blood test, potentially offering a short-cut around massive clinical trials that are increasingly difficult to conduct.

The researchers looked at the concentration of a range of virus-fighting antibodies in the blood of trial participants after they had received the vaccine developed by AstraZeneca and Oxford University, now known as Vaxzevria.

By looking at which of those trial volunteers later contracted symptomatic Covid-19 and which did not, the researchers came up with a model they hope will predict how powerful other vaccines will be, based on those blood readings.

"The data can be used to extrapolate efficacy estimates for new vaccines where large efficacy trials cannot be conducted," they said in their paper, which was posted online on Thursday and submitted for peer-review for future publication in a scientific journal.

Also Read - Delta variant to account for 90% of new Covid cases in Europe by late August

The Oxford researchers cautioned more work was needed to validate their model for many of the highly contagious new virus variants of concern.

They noted that they did not look into the so-called cellular immune response, a major weapon of the human body against infections alongside antibodies, but more difficult to measure.

"There is an urgent need to increase supply of vaccines for the world, but development and approval of new vaccines takes many months. We hope that the use of correlates by developers and regulators could speed up the process," said Andrew Pollard, director of the Oxford Vaccine Group and lead investigator on the Oxford Vaccine Trial.

Researchers and regulators around the globe are working on such benchmarks – known as a correlates of protection or surrogate endpoints - which may allow laggards in the vaccine development race to provide evidence of efficacy without having to conduct trials with tens of thousands of volunteers.

Those mass trials have so far relied on participants to contract the disease in their normal lives to provide vaccine efficacy results. That becomes more of a challenge where vaccination coverage is already high and the virus is not circulating widely.

The traditional clinical trials also require many participants to get a placebo as a comparison to those who receive the experimental vaccine, posing an ethical dilemma where approved shots are available.

Facebook 86
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail